Adial Pharmaceuticals, Inc

ADILNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

2.63M

on 2026-06-30, from 162K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-25 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

S-3 of 2025-12-12. Not read yet. S-3 ↗

18 of its filings are not read yet.

Warrants

92K

Warrants of every class as tagged in the XBRL facts on 2023-12-31. Adjusted for the 1-for-25 reverse split. 10-K ↗

Cash

10.3 quarters

$28.7M on 2026-06-30 ÷ $2.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-06-11	Private placement incl. 9.75M pre-funded	19,498,690	not read	$26.8M	8-K ↗

Also on file: a 1-for-25 reverse split, 2026-02-03 8-K ↗